Parents aren’t as informed on the latest vaccine recommendations, stretching appointments with risk and safety talks.
Many act on their advice—even over doctors’—reshaping how young consumers make decisions about healthcare.
Steady telehealth use among patients supports many market players, but winners will pair Rx access with user experience, AI, and caring providers.
Even with deep discounts, sharper digital marketing will be needed to raise awareness among cash-pay patients.
85% of healthcare orgs plan to boost agentic AI spending and expect near-term savings. Amazon has the technical edge, but may face an uphill battle against entrenched healthcare vendors.
CVS' new Health100 is designed to let consumers—even outside CVS’ network—manage their health more efficiently through tech. But industry adoption may lag.
The FDA’s latest warning wave reinforces ongoing scrutiny of telehealth and pharma promotions.
It rolled out a direct-to-employer payment model aimed at expanding weight loss drug access at work with flat pricing.
Hims & Hers’ former partner plans to continue copycat GLP-1 sales even as FDA investigations and patent lawsuits raise the risks.
New studies show the limitations of relying on AI tools for health answers. Platforms must tighten safeguards and educate users on smart prompting.
It’s unlikely to pull users from ChatGPT, but it could increase pressure on tech giants to safeguard user data and avoid overhyping their AI’s medical advice capabilities.
Chatbots and creators become go-to mental health supports for Gen Z as barriers to traditional care persist.
On today’s podcast episode, we discuss the biggest takeaways from the social media addiction trials so far, what our numbers tell us about social media usage in the US, and where else Americans spend their time consuming media. Join Senior Director of Podcasts and host Marcus Johnson, along with Principal Forecasting Writer Ethan Cramer-Flood and Senior Director of Forecasting Oscar Orozco. Listen everywhere, and watch on YouTube and Spotify.
The retailer is sidestepping in-person medical care and insurance complexities in hopes of turning pharmacy traffic into weight loss drug customers.
Brands selling health supplements need transparency around their claims, or doctors won’t recommend them to patients.
Most Americans are wary of AI, but regular users show far higher trust, proving comfort grows with experience.
Data shows the first decline in obesity rates in US adults, but children and teens moved in the opposite direction.
Videos backed by thin evidence rack up views on YouTube, raising stakes for stricter creator guidelines.
New AI capabilities add clinician-vetted, empathetic guidance for women—the predominant segment of its user base.
Drugmakers’ price drops don’t affect all patients the same. Brands and marketers must decode cost complexities where patients already seek out weight loss advice, like on social media.